Bioton S.a.
BIO.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.77 | -0.17 | -0.45 | -0.43 |
| FCF Yield | 0.64% | 2.12% | 0.48% | 4.01% |
| EV / EBITDA | 24.68 | 25.68 | 67.26 | 23.79 |
| Quality | ||||
| ROIC | 0.81% | 0.58% | -0.56% | -331.86% |
| Gross Margin | 37.06% | 32.98% | 20.96% | 28.10% |
| Cash Conversion Ratio | 0.59 | 3.08 | -1.01 | -2.77 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.80% | 6.67% | 2.75% | -3.77% |
| Free Cash Flow Growth | -67.33% | 395.27% | -84.91% | 205.03% |
| Safety | ||||
| Net Debt / EBITDA | 2.44 | 2.88 | 8.76 | 3.96 |
| Interest Coverage | 5.77 | 4.17 | -1.91 | 1.00 |
| Efficiency | ||||
| Inventory Turnover | 0.54 | 0.61 | 0.54 | 0.52 |
| Cash Conversion Cycle | 133.62 | 136.59 | 134.06 | 118.72 |